VA HB312 | 2020 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on December 31 2019 - 25% progression, died in chamber
Action: 2020-01-28 - Stricken from docket by Health, Welfare and Institutions (22-Y 0-N)
Text: Latest bill text (Prefiled) [HTML]

Summary

Board of Pharmacy; information about naloxone. Directs the Board of Pharmacy to include in each annual license renewal communication information about the dispensing, possession, and administration of naloxone or other opioid antagonist, including information about laws governing the dispensing, possession, and administration of naloxone or other opioid antagonist and civil immunity for individuals who administer naloxone or other opioid antagonist to a person believed to be experiencing an opioid overdose.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Naloxone or other opioid antagonist; communication of information by Board of Pharmacy.

Sponsors


Roll Calls

2020-01-28 - House - House: Stricken from docket by Health, Welfare and Institutions (22-Y 0-N) (Y: 22 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2020-01-28HouseStricken from docket by Health, Welfare and Institutions (22-Y 0-N)
2019-12-31HouseReferred to Committee on Health, Welfare and Institutions
2019-12-31HousePrefiled and ordered printed; offered 01/08/20 20101561D

Code Citations

ChapterArticleSectionCitation TypeStatute Text
5413309.1(n/a)See Bill Text

Virginia State Sources


Bill Comments

feedback